Feline Ureteral Obstruction: Diagnostic Imaging and Subcutaneous Ureteral Bypass Care

At a Glance

Feline ureteral obstruction is a life-threatening condition requiring prompt recognition and intervention. This article provides veterinarians with evidence-based guidance on diagnostic imaging techniques and subcutaneous ureteral bypass (SUB) device management. The content covers pathophysiology, imaging protocols, surgical indications, postoperative care, and complication management. All recommendations are derived from peer-reviewed literature and established veterinary resources.

Pathophysiology of Feline Ureteral Obstruction

Ureteral obstruction in cats most commonly results from ureterolithiasis, with calcium oxalate being the predominant stone type. The Merck Veterinary Manual notes that ureteral calculi are increasingly recognized in cats, often associated with chronic kidney disease. Obstruction leads to increased intraluminal pressure proximal to the blockage, causing hydroureter and hydronephrosis. If unrelieved, progressive nephron loss occurs within days to weeks.

The feline ureter is anatomically narrow, measuring 0.3 to 0.4 mm in diameter at its narrowest point. This predisposes cats to obstruction even by small calculi. Ureteral strictures, blood clots, inflammatory debris, and neoplasia are less common causes. Bilateral obstruction or obstruction of a solitary functional kidney constitutes a medical emergency.

Diagnostic Imaging for Ureteral Obstruction

Abdominal Ultrasound

Ultrasound is the initial imaging modality of choice for suspected ureteral obstruction. The Journal of Feline Medicine and Surgery published a comprehensive review on feline abdominal ultrasonography, detailing normal and abnormal findings of the renal pelvis, ureters, and urinary bladder. Key sonographic findings include renal pelvis dilation exceeding 2 mm, proximal ureteral dilation, and absence of a ureteral jet at the trigone.

The ureteral jet is a color Doppler finding representing urine flow from the ureter into the bladder. Its absence on the affected side strongly suggests obstruction. However, false positives occur with dehydration or low urine output. The obstructed kidney may appear normal in acute obstruction before hydronephrosis develops.

Ultrasound has limitations. The distal ureter is often obscured by gas-filled bowel. Small calculi may not cast acoustic shadows. Operator experience significantly affects diagnostic accuracy. When ultrasound findings are equivocal, advanced imaging is indicated.

Computed Tomography

CT provides superior anatomic detail compared to ultrasound. Noncontrast CT identifies ureteral calculi with high sensitivity, including radiolucent stones missed on radiography. Contrast-enhanced CT allows assessment of renal perfusion and ureteral patency. CT is particularly valuable for surgical planning, as it delineates the exact location and number of obstructions.

The Veterinary Clinics of North America review on medical and surgical management of ureteral obstructions emphasizes CT's role in complex cases. CT is indicated when ultrasound is inconclusive, when multiple obstructions are suspected, or before SUB placement. The main disadvantages are cost, need for anesthesia, and limited availability in general practice.

Excretory Urography

Excretory urography involves intravenous contrast administration followed by sequential radiographs. It provides functional information about renal excretion and ureteral patency. Delayed or absent contrast passage on the affected side confirms obstruction. This technique is less commonly used now due to the widespread availability of CT and ultrasound.

Excretory urography may be useful when advanced imaging is unavailable. It requires adequate renal function for contrast excretion. The procedure carries a risk of contrast-induced nephropathy, particularly in cats with preexisting kidney disease.

Indications for Subcutaneous Ureteral Bypass

SUB placement is indicated when medical management fails or is unlikely to succeed. The Journal of Small Animal Practice published a two-part series on feline ureteral obstructions, covering medical and surgical management. Medical management includes fluid therapy, diuretics, and ureteral relaxants, but success rates are low for complete obstructions.

Specific indications for SUB include:

• Complete ureteral obstruction refractory to medical therapy
• Ureteral stricture not amenable to balloon dilation or stenting
• Ureteral avulsion or trauma
• Obstruction in cats with concurrent chronic kidney disease where rapid decompression is needed
• Failed prior ureteral surgery or stent placement

Contraindications include uncontrolled urinary tract infection, coagulopathy, and inability to tolerate anesthesia. The decision to proceed with SUB requires careful assessment of the cat's overall health status and owner commitment to long-term monitoring.

Surgical Technique Overview

SUB placement is a minimally invasive procedure performed under general anesthesia. The device consists of a nephrostomy tube placed into the renal pelvis, a cystostomy tube placed into the urinary bladder, and a subcutaneous port connecting the two. The port is palpated percutaneously for flushing and monitoring.

The surgical approach involves ultrasound-guided or fluoroscopic-guided renal pelvis access. A guidewire is passed through the nephrostomy tube into the ureter, then into the bladder. The cystostomy tube is placed similarly. Both tubes are tunneled subcutaneously to the port, which is secured in a subcutaneous pocket.

The Journal of Small Animal Practice review on surgical management of feline ureteral obstructions provides detailed technical guidance. Key surgical considerations include:

• Aseptic technique throughout
• Confirmation of proper tube placement with contrast injection
• Securing all connections to prevent dislodgement
• Flushing the system to confirm patency before closure

Postoperative imaging confirms device position and function. The nephrostomy tube should terminate in the renal pelvis without kinking. The cystostomy tube should lie freely within the bladder lumen.

Postoperative Care and Monitoring

Immediate postoperative care focuses on pain management, fluid therapy, and monitoring for complications. Cats typically require hospitalization for 24 to 72 hours. Urine output should be monitored closely, as postobstructive diuresis is common.

The SUB device requires regular flushing to maintain patency. Flushing is performed using sterile saline through the subcutaneous port. The frequency of flushing varies by protocol but typically ranges from every 2 to 4 weeks initially, then every 1 to 3 months long-term.

Monitoring parameters include:

• Serial renal function tests (creatinine, BUN, electrolytes)
• Urinalysis and urine culture
• Ultrasound to assess renal pelvis size and device position
• Port palpation to detect subcutaneous fluid accumulation

The Merck Veterinary Manual emphasizes the importance of long-term follow-up in cats with chronic kidney disease. Many cats with ureteral obstruction have preexisting renal impairment that requires ongoing management.

Common Complications and Management

Device Obstruction

Device obstruction is the most common complication, occurring in 10 to 30% of cases. Obstruction may result from blood clots, cellular debris, or mineralized deposits. Flushing the device with sterile saline often resolves acute obstruction. Persistent obstruction requires investigation with contrast imaging.

Urinary Tract Infection

Urinary tract infection is a frequent complication, with reported rates of 20 to 40%. The indwelling device provides a nidus for bacterial colonization. Regular urine culture is essential. Antibiotic therapy should be guided by culture and sensitivity results. The World Organisation for Animal Health provides guidelines for antimicrobial stewardship in veterinary practice.

Device Dislodgement

Nephrostomy or cystostomy tube dislodgement is a serious complication requiring immediate intervention. Dislodgement may occur with trauma or excessive patient activity. Cats should be confined during the initial postoperative period. If dislodgement occurs, surgical replacement is typically required.

Port Site Complications

Port site seroma, infection, or erosion may occur. Seromas often resolve with conservative management. Port site infection requires systemic antibiotics and possibly device removal. Port erosion through the skin necessitates surgical revision.

Hematuria

Hematuria is common in the immediate postoperative period and usually resolves spontaneously. Persistent or worsening hematuria warrants investigation for device-related trauma or infection.

Records and Measurements

Accurate record keeping is essential for managing cats with SUB devices. The following parameters should be documented at each visit:

• Date and time of device placement
• Device type and lot number
• Baseline renal function values
• Flushing frequency and volume
• Any complications and their management
• Urine culture results
• Ultrasound findings (renal pelvis size, device position)

Serial creatinine measurements are critical for assessing renal function. A rising creatinine may indicate device obstruction or progressive kidney disease. The Journal of Veterinary Internal Medicine published a study on outcomes of benign ureteral obstruction in cats managed medically, highlighting the importance of monitoring renal function over time.

Common Failure Patterns

Delayed Diagnosis

Delayed diagnosis is a common failure pattern in feline ureteral obstruction. Cats often present with nonspecific signs such as anorexia, lethargy, and vomiting. Azotemia may be attributed to primary kidney disease instead of obstruction. A high index of suspicion is necessary, particularly in cats with known ureterolithiasis or chronic kidney disease.

Inadequate Imaging

Inadequate imaging leads to missed or incomplete diagnosis. Ultrasound alone may miss distal ureteral obstructions. CT should be considered when ultrasound findings are equivocal. The Journal of Feline Medicine and Surgery review emphasizes the importance of systematic ultrasound evaluation of the entire urinary tract.

Suboptimal Device Management

Suboptimal device management contributes to complications. Inconsistent flushing, failure to monitor renal function, and delayed recognition of infection are common errors. Owner education is critical for long-term success. Owners should be trained to recognize signs of device obstruction or infection.

Failure to Address Underlying Disease

Ureteral obstruction is often a manifestation of underlying urolithiasis or chronic kidney disease. Failure to address the underlying disease leads to recurrence. Dietary modification, increased water intake, and medical management of hypercalcemia may reduce stone recurrence.

Welfare and Safety Context

Feline ureteral obstruction is a painful condition that causes significant distress. Prompt diagnosis and treatment are essential for animal welfare. The World Organisation for Animal Health emphasizes the importance of timely veterinary intervention in obstructive uropathies.

SUB placement provides rapid relief of obstruction and preserves renal function. However, the procedure carries inherent risks, including anesthesia-related complications, infection, and device failure. Veterinarians must balance the benefits of intervention against the risks for each individual patient.

Long-term welfare considerations include the need for regular veterinary visits, device flushing, and monitoring. Some cats tolerate the device well with minimal impact on quality of life. Others may experience recurrent complications requiring additional interventions.

Professional Escalation Criteria

Veterinarians should consider referral to a specialist in the following situations:

• Inability to confirm obstruction with available imaging
• Complex obstruction not amenable to standard surgical techniques
• Recurrent device obstruction or infection
• Progressive renal decline despite patent device
• Need for device revision or removal

The American College of Veterinary Internal Medicine provides resources for locating board-certified specialists in internal medicine and surgery. Early referral improves outcomes in complex cases.

Decision Framework for Selecting Between Medical Management, Ureteral Stenting, and SUB Placement

Selecting the appropriate intervention for feline ureteral obstruction requires a structured decision process that integrates diagnostic findings, patient characteristics, and owner resources. The Journal of Small Animal Practice series on feline ureteral obstructions provides evidence that medical management alone succeeds in only a minority of complete obstructions, while surgical options carry distinct risk profiles. This section presents a practical decision framework to guide clinicians through the selection process, including specific criteria for each option, a record system for tracking decision-relevant parameters, and troubleshooting methods for common decision-making pitfalls.

Tiered Decision Algorithm

The decision algorithm begins with three critical determinations: obstruction completeness, patient stability, and renal functional reserve. Complete obstruction is defined as absence of contrast passage beyond the obstruction site on imaging or absence of a ureteral jet on Doppler ultrasound. The Journal of Veterinary Internal Medicine study on benign ureteral obstruction outcomes emphasizes that complete obstructions rarely resolve with medical management alone.

Tier 1: Immediate Intervention Required

Proceed directly to SUB placement or ureteral stenting when any of the following are present:

• Bilateral complete obstruction
• Obstruction of a solitary functional kidney
• Severe azotemia (creatinine >5.0 mg/dL) with complete obstruction
• Life-threatening hyperkalemia (potassium >6.5 mEq/L) refractory to medical therapy
• Ureteral avulsion or traumatic disruption

These scenarios represent surgical emergencies where delay increases mortality risk. The Veterinary Clinics of North America review on medical and surgical management notes that rapid decompression in these cases preserves remaining nephron mass.

Tier 2: Medical Trial Appropriate

Consider a 24 to 48 hour medical trial when all of the following criteria are met:

• Partial obstruction confirmed by contrast passage or intermittent ureteral jet
• Unilateral obstruction with contralateral kidney function adequate to maintain stability
• Creatinine <4.0 mg/dL
• No evidence of ureteral stricture or neoplasia
• Owner willing and able to monitor closely and return for reassessment

Medical management includes intravenous fluid therapy at maintenance to 1.5 times maintenance rates, mannitol (0.25 to 0.5 g/kg IV over 15 to 30 minutes) or furosemide (1 to 2 mg/kg IV) to promote diuresis, and ureteral relaxants such as prazosin (0.25 to 0.5 mg per cat orally every 12 to 24 hours) or terbutaline (0.625 to 1.25 mg per cat orally every 12 hours). The Merck Veterinary Manual notes that medical therapy success rates are highest for small calculi (<2 mm) and partial obstructions.

Reassess at 24 and 48 hours with repeat ultrasound and renal function testing. Proceed to surgical intervention if any of the following occur:

• Worsening azotemia
• Increasing renal pelvis dilation
• Persistent absence of ureteral jet
• Development of clinical signs (anorexia, vomiting, lethargy)

Tier 3: Surgical Option Selection

When surgical intervention is indicated, choose between ureteral stenting and SUB placement based on the following criteria:

Ureteral Stenting Preferred When:

• Obstruction is distal (within 2 cm of the trigone)
• Ureteral lumen is patent enough to pass a guidewire
• No concurrent ureteral stricture
• Stone burden is limited (single calculus or small cluster)
• Owner can commit to potential future endoscopic removal

SUB Placement Preferred When:

• Obstruction is proximal (within 2 cm of the renal pelvis)
• Ureteral stricture is present
• Prior ureteral surgery or stenting has failed
• Ureteral lumen is too narrow for stent passage
• Multiple or large calculi are present
• Concurrent chronic kidney disease requires rapid decompression

The Journal of Small Animal Practice surgical management review indicates that SUB placement has become the preferred option for many surgeons due to its lower complication rate compared to traditional ureteral surgery and its effectiveness in stricture cases.

Record System for Decision Tracking

A structured record system ensures consistent application of the decision framework and facilitates communication with owners and referral centers. The following parameters should be documented at initial presentation and at each reassessment point.

Initial Presentation Record

Reassessment Record (24 and 48 hours)

Surgical Decision Record

This record system allows objective tracking of patient progress and provides clear documentation for referral if needed.

Troubleshooting Common Decision-Making Pitfalls

Pitfall 1: Equivocal Imaging Results

When ultrasound findings are inconclusive, the decision framework may stall. The Journal of Feline Medicine and Surgery review on abdominal ultrasonography notes that operator experience significantly affects diagnostic accuracy. If the ureteral jet is absent but hydronephrosis is mild (<3 mm), consider the following troubleshooting steps:

• Repeat ultrasound after fluid bolus (20 mL/kg IV crystalloid over 15 to 30 minutes)
• Perform color Doppler evaluation of both ureteral jets for at least 5 minutes
• Obtain CT if available, as it provides definitive characterization
• Consider excretory urography if CT is unavailable

If imaging remains equivocal but clinical suspicion is high, proceed with CT or referral instead of delaying intervention.

Pitfall 2: Rapid Clinical Deterioration

A cat that deteriorates during the medical trial period requires immediate escalation. Signs of deterioration include:

• Creatinine increase >0.5 mg/dL in 24 hours
• Potassium increase >0.5 mEq/L in 24 hours
• Development of uremic signs (vomiting, oral ulcers, depression)
• Oliguria or anuria

In these cases, abandon the medical trial and proceed directly to surgical intervention. The decision between stent and SUB should be made based on preoperative imaging, but if imaging is incomplete, SUB is often preferred as it bypasses the ureter entirely and does not require ureteral lumen patency.

Pitfall 3: Owner Hesitation or Financial Constraints

When owners are hesitant about surgical intervention, provide clear outcome data. The Journal of Veterinary Internal Medicine study on benign ureteral obstruction outcomes reports that cats managed medically have higher rates of progressive azotemia and mortality compared to those receiving surgical intervention. The Journal of Small Animal Practice medical management review indicates that only 10 to 20% of complete obstructions resolve with medical therapy alone.

If financial constraints limit options, discuss the following alternatives:

• Medical management with close monitoring (lowest cost, lowest success rate)
• Ureteral stenting (moderate cost, moderate success rate)
• SUB placement (higher cost, highest success rate for complex cases)
• Euthanasia if prognosis is poor and treatment is not feasible

Document all discussions and owner decisions in the medical record.

Pitfall 4: Recurrent Obstruction After Initial Success

If a cat with a SUB device develops recurrent obstruction, the decision framework must be reapplied. Troubleshooting steps include:

• Flush the device with sterile saline through the port
• If flushing does not restore patency, perform contrast imaging through the port to identify the obstruction site
• Obtain urine culture to rule out infection as a contributing factor
• Assess renal function to determine if the obstruction is causing significant azotemia

If the device is obstructed and flushing fails, surgical revision or replacement is typically required. The Veterinary Clinics of North America review notes that recurrent obstruction is more common with mineralized deposits and in cats with persistent hypercalcemia.

Comparison of Surgical Options: Stenting versus SUB

The Journal of Small Animal Practice surgical management review provides evidence that both options have acceptable outcomes, but SUB placement is increasingly preferred for complex cases due to its lower technical difficulty and effectiveness in stricture management.

Practical Implementation Steps

Step 1: Obtain Complete Diagnostic Information

Before making a treatment decision, ensure the following information is available:

• Complete blood count, serum biochemistry, and urinalysis
• Abdominal ultrasound with Doppler evaluation of ureteral jets
• CT if ultrasound is inconclusive or if surgical planning requires precise anatomic detail
• Urine culture if infection is suspected

Step 2: Classify Obstruction Severity

Use the following classification system:

• Mild: Renal pelvis dilation 2 to 5 mm, partial obstruction, creatinine <3.0 mg/dL
• Moderate: Renal pelvis dilation 5 to 10 mm, complete obstruction, creatinine 3.0 to 5.0 mg/dL
• Severe: Renal pelvis dilation >10 mm, complete obstruction, creatinine >5.0 mg/dL, bilateral or solitary kidney involvement

Step 3: Apply Decision Algorithm

Use the tiered algorithm described above to select the appropriate intervention. Document the rationale for the decision in the medical record.

Step 4: Discuss Options with Owner

Provide owners with a clear explanation of the risks and benefits of each option. Include estimated costs, expected outcomes, and long-term management requirements. The Merck Veterinary Manual emphasizes the importance of owner education in achieving successful long-term outcomes.

Step 5: Implement and Monitor

After intervention, implement the monitoring protocol described in the postoperative care section. Use the record system to track progress and identify complications early.

Professional Escalation Criteria for Decision-Making

Refer to a specialist when:

• The decision between stent and SUB is unclear based on available imaging
• The obstruction is complex (multiple stones, stricture, prior surgery)
• The cat has significant comorbidities that complicate anesthetic management
• The owner requests a second opinion
• The clinician lacks experience with the selected surgical technique

The American College of Veterinary Internal Medicine provides resources for locating board-certified specialists in internal medicine and surgery. Early referral in complex cases improves outcomes and reduces the risk of complications.

Decision Framework for Selecting Between Medical Management, Ureteral Stenting, and SUB Placement

Selecting the appropriate intervention for feline ureteral obstruction requires a structured decision process that integrates diagnostic findings, patient characteristics, and owner resources. The Journal of Small Animal Practice series on feline ureteral obstructions provides evidence that medical management alone succeeds in only a minority of complete obstructions, while surgical options carry distinct risk profiles. This section presents a practical decision framework to guide clinicians through the selection process, including specific criteria for each option, a record system for tracking decision-relevant parameters, and troubleshooting methods for common decision-making pitfalls.

Tiered Decision Algorithm

The decision algorithm begins with three critical determinations: obstruction completeness, patient stability, and renal functional reserve. Complete obstruction is defined as absence of contrast passage beyond the obstruction site on imaging or absence of a ureteral jet on Doppler ultrasound. The Journal of Veterinary Internal Medicine study on benign ureteral obstruction outcomes emphasizes that complete obstructions rarely resolve with medical management alone.

Tier 1: Immediate Intervention Required

Proceed directly to SUB placement or ureteral stenting when any of the following are present:

• Bilateral complete obstruction
• Obstruction of a solitary functional kidney
• Severe azotemia (creatinine >5.0 mg/dL) with complete obstruction
• Life-threatening hyperkalemia (potassium >6.5 mEq/L) refractory to medical therapy
• Ureteral avulsion or traumatic disruption

These scenarios represent surgical emergencies where delay increases mortality risk. The Veterinary Clinics of North America review on medical and surgical management notes that rapid decompression in these cases preserves remaining nephron mass.

Tier 2: Medical Trial Appropriate

Consider a 24 to 48 hour medical trial when all of the following criteria are met:

• Partial obstruction confirmed by contrast passage or intermittent ureteral jet
• Unilateral obstruction with contralateral kidney function adequate to maintain stability
• Creatinine <4.0 mg/dL
• No evidence of ureteral stricture or neoplasia
• Owner willing and able to monitor closely and return for reassessment

Medical management includes intravenous fluid therapy at maintenance to 1.5 times maintenance rates, mannitol (0.25 to 0.5 g/kg IV over 15 to 30 minutes) or furosemide (1 to 2 mg/kg IV) to promote diuresis, and ureteral relaxants such as prazosin (0.25 to 0.5 mg per cat orally every 12 to 24 hours) or terbutaline (0.625 to 1.25 mg per cat orally every 12 hours). The Merck Veterinary Manual notes that medical therapy success rates are highest for small calculi (<2 mm) and partial obstructions.

Reassess at 24 and 48 hours with repeat ultrasound and renal function testing. Proceed to surgical intervention if any of the following occur:

• Worsening azotemia
• Increasing renal pelvis dilation
• Persistent absence of ureteral jet
• Development of clinical signs (anorexia, vomiting, lethargy)

Tier 3: Surgical Option Selection

When surgical intervention is indicated, choose between ureteral stenting and SUB placement based on the following criteria:

Ureteral Stenting Preferred When:

• Obstruction is distal (within 2 cm of the trigone)
• Ureteral lumen is patent enough to pass a guidewire
• No concurrent ureteral stricture
• Stone burden is limited (single calculus or small cluster)
• Owner can commit to potential future endoscopic removal

SUB Placement Preferred When:

• Obstruction is proximal (within 2 cm of the renal pelvis)
• Ureteral stricture is present
• Prior ureteral surgery or stenting has failed
• Ureteral lumen is too narrow for stent passage
• Multiple or large calculi are present
• Concurrent chronic kidney disease requires rapid decompression

The Journal of Small Animal Practice surgical management review indicates that SUB placement has become the preferred option for many surgeons due to its lower complication rate compared to traditional ureteral surgery and its effectiveness in stricture cases.

Record System for Decision Tracking

A structured record system ensures consistent application of the decision framework and facilitates communication with owners and referral centers. The following parameters should be documented at initial presentation and at each reassessment point.

Initial Presentation Record

Reassessment Record (24 and 48 hours)

Surgical Decision Record

This record system allows objective tracking of patient progress and provides clear documentation for referral if needed.

Troubleshooting Common Decision-Making Pitfalls

Pitfall 1: Equivocal Imaging Results

When ultrasound findings are inconclusive, the decision framework may stall. The Journal of Feline Medicine and Surgery review on abdominal ultrasonography notes that operator experience significantly affects diagnostic accuracy. If the ureteral jet is absent but hydronephrosis is mild (<3 mm), consider the following troubleshooting steps:

• Repeat ultrasound after fluid bolus (20 mL/kg IV crystalloid over 15 to 30 minutes)
• Perform color Doppler evaluation of both ureteral jets for at least 5 minutes
• Obtain CT if available, as it provides definitive characterization
• Consider excretory urography if CT is unavailable

If imaging remains equivocal but clinical suspicion is high, proceed with CT or referral instead of delaying intervention.

Pitfall 2: Rapid Clinical Deterioration

A cat that deteriorates during the medical trial period requires immediate escalation. Signs of deterioration include:

• Creatinine increase >0.5 mg/dL in 24 hours
• Potassium increase >0.5 mEq/L in 24 hours
• Development of uremic signs (vomiting, oral ulcers, depression)
• Oliguria or anuria

In these cases, abandon the medical trial and proceed directly to surgical intervention. The decision between stent and SUB should be made based on preoperative imaging, but if imaging is incomplete, SUB is often preferred as it bypasses the ureter entirely and does not require ureteral lumen patency.

Pitfall 3: Owner Hesitation or Financial Constraints

When owners are hesitant about surgical intervention, provide clear outcome data. The Journal of Veterinary Internal Medicine study on benign ureteral obstruction outcomes reports that cats managed medically have higher rates of progressive azotemia and mortality compared to those receiving surgical intervention. The Journal of Small Animal Practice medical management review indicates that only 10 to 20% of complete obstructions resolve with medical therapy alone.

If financial constraints limit options, discuss the following alternatives:

• Medical management with close monitoring (lowest cost, lowest success rate)
• Ureteral stenting (moderate cost, moderate success rate)
• SUB placement (higher cost, highest success rate for complex cases)
• Euthanasia if prognosis is poor and treatment is not feasible

Document all discussions and owner decisions in the medical record.

Pitfall 4: Recurrent Obstruction After Initial Success

If a cat with a SUB device develops recurrent obstruction, the decision framework must be reapplied. Troubleshooting steps include:

• Flush the device with sterile saline through the port
• If flushing does not restore patency, perform contrast imaging through the port to identify the obstruction site
• Obtain urine culture to rule out infection as a contributing factor
• Assess renal function to determine if the obstruction is causing significant azotemia

If the device is obstructed and flushing fails, surgical revision or replacement is typically required. The Veterinary Clinics of North America review notes that recurrent obstruction is more common with mineralized deposits and in cats with persistent hypercalcemia.

Comparison of Surgical Options: Stenting versus SUB

The Journal of Small Animal Practice surgical management review provides evidence that both options have acceptable outcomes, but SUB placement is increasingly preferred for complex cases due to its lower technical difficulty and effectiveness in stricture management.

Practical Implementation Steps

Step 1: Obtain Complete Diagnostic Information

Before making a treatment decision, ensure the following information is available:

• Complete blood count, serum biochemistry, and urinalysis
• Abdominal ultrasound with Doppler evaluation of ureteral jets
• CT if ultrasound is inconclusive or if surgical planning requires precise anatomic detail
• Urine culture if infection is suspected

Step 2: Classify Obstruction Severity

Use the following classification system:

• Mild: Renal pelvis dilation 2 to 5 mm, partial obstruction, creatinine <3.0 mg/dL
• Moderate: Renal pelvis dilation 5 to 10 mm, complete obstruction, creatinine 3.0 to 5.0 mg/dL
• Severe: Renal pelvis dilation >10 mm, complete obstruction, creatinine >5.0 mg/dL, bilateral or solitary kidney involvement

Step 3: Apply Decision Algorithm

Use the tiered algorithm described above to select the appropriate intervention. Document the rationale for the decision in the medical record.

Step 4: Discuss Options with Owner

Provide owners with a clear explanation of the risks and benefits of each option. Include estimated costs, expected outcomes, and long-term management requirements. The Merck Veterinary Manual emphasizes the importance of owner education in achieving successful long-term outcomes.

Step 5: Implement and Monitor

After intervention, implement the monitoring protocol described in the postoperative care section. Use the record system to track progress and identify complications early.

Professional Escalation Criteria for Decision-Making

Refer to a specialist when:

• The decision between stent and SUB is unclear based on available imaging
• The obstruction is complex (multiple stones, stricture, prior surgery)
• The cat has significant comorbidities that complicate anesthetic management
• The owner requests a second opinion
• The clinician lacks experience with the selected surgical technique

The American College of Veterinary Internal Medicine provides resources for locating board-certified specialists in internal medicine and surgery. Early referral in complex cases improves outcomes and reduces the risk of complications.

Frequently Asked Questions

What is the most common cause of ureteral obstruction in cats?

Ureteral obstruction in cats most commonly results from ureterolithiasis, with calcium oxalate being the predominant stone type. Less common causes include ureteral strictures, blood clots, inflammatory debris, and neoplasia.

How is feline ureteral obstruction diagnosed?

Diagnosis begins with abdominal ultrasound to identify hydronephrosis and proximal ureteral dilation. Computed tomography provides definitive characterization when ultrasound is inconclusive. Excretory urography may be used when advanced imaging is unavailable.

What are the indications for subcutaneous ureteral bypass placement?

SUB placement is indicated for complete ureteral obstruction refractory to medical therapy, ureteral stricture not amenable to balloon dilation, ureteral trauma, obstruction in cats with concurrent chronic kidney disease, and failed prior ureteral surgery or stent placement.

How often does a SUB device need to be flushed?

Flushing frequency varies by protocol but typically ranges from every 2 to 4 weeks initially, then every 1 to 3 months long-term. The device is flushed with sterile saline through the subcutaneous port.

What are the most common complications of SUB devices?

Device obstruction is the most common complication, occurring in 10 to 30% of cases. Urinary tract infection is also frequent, with reported rates of 20 to 40%. Device dislodgement and port site complications are less common but require prompt intervention.

Can a cat live a normal life with a SUB device?

Many cats tolerate the SUB device well with minimal impact on quality of life. However, long-term monitoring and regular veterinary visits are required. Some cats experience recurrent complications requiring additional interventions.

What monitoring is required after SUB placement?

Monitoring includes serial renal function tests, urinalysis and urine culture, ultrasound to assess renal pelvis size and device position, and port palpation to detect subcutaneous fluid accumulation. Regular veterinary follow-up is essential.

When should a cat with a SUB device be referred to a specialist?

Referral is indicated when the obstruction cannot be confirmed with available imaging, when complex obstruction is not amenable to standard techniques, when recurrent device obstruction or infection occurs, when renal function declines despite a patent device, or when device revision or removal is needed.

Related Veterinary Guides

• Cat
• Canine Immune Mediated Polyarthritis Diagnosis Management
• Canine Polycystic Kidney Disease Diagnosis Management
• Hypertrophic Cardiomyopathy In Cats
• Prescription Medicine For Cats

References and Further Reading

• www.merckvetmanual.com
• www.acvim.org
• Merck Veterinary Manual. Merck Veterinary Manual.
• Animal Health and Welfare. World Organisation for Animal Health.
• Feline ureteral obstructions Part 1: medical management.. The Journal of small animal practice, 2018.
• Medical and Surgical Management of Ureteral Obstructions.. The Veterinary clinics of North America. Small animal practice, 2025.
• Benign ureteral obstruction in cats: Outcome with medical management.. Journal of veterinary internal medicine, 2023.
• Feline abdominal ultrasonography: What's normal? What's abnormal? Renal pelvis, ureters and urinary bladder.. Journal of feline medicine and surgery, 2020.
• Ureteral obstructions in dogs and cats: a review of traditional and new interventional diagnostic and therapeutic options.. Journal of veterinary emergency and critical care (San Antonio, Tex. : 2001), 2011.
• Feline ureteral obstructions Part 2: surgical management.. The Journal of small animal practice, 2018.
• Bilateral ureterolithiasis in a 7-month-old cat. Ciencia Rural, 2021.
• Ureteral calculi in cats: Retrospective study of 34 cases. Bulletin De L Academie Veterinaire De France, 2017.
• Calcium oxalate ureterolithiasis in a cat. Acta Scientiae Veterinariae, 2015.
• Calcium oxalate ureterolithiasis in a cat. Acta Veterinaria Brasilica, 2013.

This article is educational and is not a substitute for veterinary diagnosis or treatment. Contact a veterinarian for advice about an individual animal.